logo-loader
viewOxford BioMedica plc

Capital Network's Lowi says Oxford Biomedica research area is 'novel and promising'

Capital Network analyst Riccardo Lowi discusses Oxford Biomedica's (LON:OXB) market opportunity and says its research area is 'novel and promising'.

Quick facts: Oxford BioMedica plc

Price: 655 GBX

AIM:OXB
Market: AIM
Market Cap: £503.43 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Immotion plans fundraising following deal with Las Vegas resort

Immotion Group (LON:IMMO) has raised gross proceeds of £2.85mln from an 'oversubscribed' fundraising to accelerate its growth plans, and revealed it has inked a revenue-sharing deal with the MGM Mandalay Bay resort and casino in Las Vegas. CEO Martin Higginson tells Proactive London what the...

2 days, 15 hours ago

2 min read